Geethakumari Prabhitha, Kampa Prathima, Parchuri Rakesh, Bhandari Renu, Alnasser Ali R, Akram Aqsa, Kar Saikat, Osman Fatema, Mashat Ghadi D, Tran Hadrian Hoang-Vu, Urgessa Neway A, Yu Ann Kashmer
Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Internal Medicine/Family Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Cureus. 2022 Oct 6;14(10):e29967. doi: 10.7759/cureus.29967. eCollection 2022 Oct.
Ultrasonography and elastography are the most widely used imaging modalities for diagnosing non-alcoholic fatty liver disease. This study aimed to assess and compare the diagnostic accuracy in patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. This systematic review was based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. A systematic search was done for the past seven years using Pubmed, Pubmed Central, Cochrane, and Google Scholar databases on Jun 29, 2022. Studies were included based on the following predefined criteria: observational studies, randomized controlled trial (RCT), comparative studies, studies using liver biopsy or MRI proton density fat fraction (MRI PDFF) as a reference standard, ultrasonography, and elastography with measures of their diagnostic accuracy like sensitivity (SN), specificity (SP), area under the receiver operating characteristic (AUROC) curve, and English language. The data were extracted on a predefined template. The final twelve eligible studies were assessed using the quality assessment of diagnostic accuracy tool (QUADS-2). Most studies focused on elastography techniques, and the remaining focused on quantitative ultrasonography methods like the controlled attenuation parameter (CAP) and attenuation coefficient (AC). Only one study was available for the evaluation of qualitative ultrasonography. MRI was generally found superior to other diagnostic tests for determining liver stiffness through magnetic resonance elastography (MRE) and steatosis through MRI PDFF. Data assessing the comparative diagnostic accuracy of the two tests were inconclusive.
超声检查和弹性成像技术是诊断非酒精性脂肪性肝病最常用的成像方式。本研究旨在评估和比较非酒精性脂肪性肝病/非酒精性脂肪性肝炎患者的诊断准确性。本系统评价基于系统评价和Meta分析的首选报告项目(PRISMA)指南。2022年6月29日,使用PubMed、PubMed Central、Cochrane和谷歌学术数据库对过去七年进行了系统检索。根据以下预定义标准纳入研究:观察性研究、随机对照试验(RCT)、比较性研究、以肝活检或MRI质子密度脂肪分数(MRI PDFF)作为参考标准的研究、超声检查和弹性成像技术,并测量其诊断准确性指标,如敏感性(SN)、特异性(SP)、受试者操作特征曲线下面积(AUROC),且语言为英语。数据按照预定义模板提取。使用诊断准确性工具质量评估(QUADS - 2)对最终的12项合格研究进行评估。大多数研究聚焦于弹性成像技术,其余研究聚焦于定量超声检查方法,如受控衰减参数(CAP)和衰减系数(AC)。仅有一项研究可用于评估定性超声检查。一般发现,通过磁共振弹性成像(MRE)测定肝脏硬度以及通过MRI PDFF测定脂肪变性时,MRI优于其他诊断测试。评估这两种检查比较诊断准确性的数据尚无定论。